Skip to main content
Top
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients

Authors: Jürgen Hoffmann, Diethelm Wallwiener

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

One of the basic prerequisites for generating evidence-based data is the availability of classification systems. Attempts to date to classify breast cancer operations have focussed on specific problems, e.g. the avoidance of secondary corrective surgery for surgical defects, rather than taking a generic approach.

Methods

Starting from an existing, simpler empirical scheme based on the complexity of breast surgical procedures, which was used in-house primarily in operative report-writing, a novel classification of ablative and breast-conserving procedures initially needed to be developed and elaborated systematically. To obtain proof of principle, a prospectively planned analysis of patient records for all major breast cancer-related operations performed at our breast centre in 2005 and 2006 was conducted using the new classification. Data were analysed using basic descriptive statistics such as frequency tables.

Results

A novel two-type, six-tier classification system comprising 12 main categories, 13 subcategories and 39 sub-subcategories of oncological, oncoplastic and reconstructive breast cancer-related surgery was successfully developed. Our system permitted unequivocal classification, without exception, of all 1225 procedures performed in 1166 breast cancer patients in 2005 and 2006.

Conclusion

Breast cancer-related surgical procedures can be generically classified according to their surgical complexity. Analysis of all major procedures performed at our breast centre during the study period provides proof of principle for this novel classification system. We envisage various applications for this classification, including uses in randomised clinical trials, guideline development, specialist surgical training, continuing professional development as well as quality of care and public health research.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cady B, Falkenberry SS, Chung MA: The surgeon's role in outcome in contemporary breast cancer. Surg Oncol Clin N Am. 2000, 9 (1): 119-132. viiiPubMed Cady B, Falkenberry SS, Chung MA: The surgeon's role in outcome in contemporary breast cancer. Surg Oncol Clin N Am. 2000, 9 (1): 119-132. viiiPubMed
2.
go back to reference Peto R: Meta-analysis on local therapy. Oral presentation. 27th San Antonio Breast Cancer Symposium. 2004 Peto R: Meta-analysis on local therapy. Oral presentation. 27th San Antonio Breast Cancer Symposium. 2004
3.
go back to reference Fisher B, Wolmark N: New concepts in the management of primary breast cancer. Cancer. 1975, 36 (2): 627-632. 10.1002/1097-0142(197508)36:2+<627::AID-CNCR2820360803>3.0.CO;2-1.CrossRefPubMed Fisher B, Wolmark N: New concepts in the management of primary breast cancer. Cancer. 1975, 36 (2): 627-632. 10.1002/1097-0142(197508)36:2+<627::AID-CNCR2820360803>3.0.CO;2-1.CrossRefPubMed
4.
go back to reference Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, et al: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976, 294 (8): 405-410.CrossRefPubMed Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, et al: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976, 294 (8): 405-410.CrossRefPubMed
5.
go back to reference Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A: Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet. 2001, 358 (9278): 277-286. 10.1016/S0140-6736(01)05483-6.CrossRefPubMed Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A: Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet. 2001, 358 (9278): 277-286. 10.1016/S0140-6736(01)05483-6.CrossRefPubMed
7.
go back to reference Elstein AS: On the origins and development of evidence-based medicine and medical decision making. Inflamm Res. 2004, 53 (Suppl 2): S184-189.PubMed Elstein AS: On the origins and development of evidence-based medicine and medical decision making. Inflamm Res. 2004, 53 (Suppl 2): S184-189.PubMed
8.
go back to reference Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 1995, 333 (22): 1444-1455. 10.1056/NEJM199511303332202.CrossRef Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 1995, 333 (22): 1444-1455. 10.1056/NEJM199511303332202.CrossRef
9.
go back to reference Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000, 355 (9217): 1757-1770. 10.1016/S0140-6736(00)02263-7.CrossRef Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000, 355 (9217): 1757-1770. 10.1016/S0140-6736(00)02263-7.CrossRef
10.
go back to reference van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, Schueren van der E, Helle PA, van Zijl K, Bartelink H: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000, 92 (14): 1143-1150. 10.1093/jnci/92.14.1143.CrossRefPubMed van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, Schueren van der E, Helle PA, van Zijl K, Bartelink H: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000, 92 (14): 1143-1150. 10.1093/jnci/92.14.1143.CrossRefPubMed
11.
go back to reference Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002, 347 (16): 1233-1241. 10.1056/NEJMoa022152.CrossRefPubMed Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002, 347 (16): 1233-1241. 10.1056/NEJMoa022152.CrossRefPubMed
12.
go back to reference Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002, 347 (16): 1227-1232. 10.1056/NEJMoa020989.CrossRefPubMed Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002, 347 (16): 1227-1232. 10.1056/NEJMoa020989.CrossRefPubMed
13.
go back to reference Rutgers EJ: Quality control in the locoregional treatment of breast cancer. Eur J Cancer. 2001, 37 (4): 447-453. 10.1016/S0959-8049(00)00386-5.CrossRefPubMed Rutgers EJ: Quality control in the locoregional treatment of breast cancer. Eur J Cancer. 2001, 37 (4): 447-453. 10.1016/S0959-8049(00)00386-5.CrossRefPubMed
14.
go back to reference Rew DA: Towards a scientific basis for oncoplastic breast surgery. Eur J Surg Oncol. 2003, 29 (2): 105-106. 10.1053/ejso.2002.1410.CrossRefPubMed Rew DA: Towards a scientific basis for oncoplastic breast surgery. Eur J Surg Oncol. 2003, 29 (2): 105-106. 10.1053/ejso.2002.1410.CrossRefPubMed
15.
go back to reference Birido N, Geraghty JG: Quality control in breast cancer surgery. Eur J Surg Oncol. 2005, 31 (6): 577-586. 10.1016/j.ejso.2005.02.009.CrossRefPubMed Birido N, Geraghty JG: Quality control in breast cancer surgery. Eur J Surg Oncol. 2005, 31 (6): 577-586. 10.1016/j.ejso.2005.02.009.CrossRefPubMed
16.
go back to reference Benson JR, Querci della Rovere G: Towards a scientific basis for oncoplastic breast surgery. Eur J Surg Oncol. 2003, 29 (7): 629-10.1016/S0748-7983(03)00113-6.CrossRefPubMed Benson JR, Querci della Rovere G: Towards a scientific basis for oncoplastic breast surgery. Eur J Surg Oncol. 2003, 29 (7): 629-10.1016/S0748-7983(03)00113-6.CrossRefPubMed
17.
go back to reference Asgeirsson KS, Rasheed T, McCulley SJ, Macmillan RD: Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. Eur J Surg Oncol. 2005, 31 (8): 817-823. 10.1016/j.ejso.2005.05.010.CrossRefPubMed Asgeirsson KS, Rasheed T, McCulley SJ, Macmillan RD: Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. Eur J Surg Oncol. 2005, 31 (8): 817-823. 10.1016/j.ejso.2005.05.010.CrossRefPubMed
18.
go back to reference Clough KB, Cuminet J, Fitoussi A, Nos C, Mosseri V: Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg. 1998, 41 (5): 471-481. 10.1097/00000637-199811000-00004.CrossRefPubMed Clough KB, Cuminet J, Fitoussi A, Nos C, Mosseri V: Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg. 1998, 41 (5): 471-481. 10.1097/00000637-199811000-00004.CrossRefPubMed
19.
go back to reference Clough KB, Thomas SS, Fitoussi AD, Couturaud B, Reyal F, Falcou MC: Reconstruction after conservative treatment for breast cancer: cosmetic sequelae classification revisited. Plast Reconstr Surg. 2004, 114 (7): 1743-1753. 10.1097/01.PRS.0000142442.62956.78.CrossRefPubMed Clough KB, Thomas SS, Fitoussi AD, Couturaud B, Reyal F, Falcou MC: Reconstruction after conservative treatment for breast cancer: cosmetic sequelae classification revisited. Plast Reconstr Surg. 2004, 114 (7): 1743-1753. 10.1097/01.PRS.0000142442.62956.78.CrossRefPubMed
20.
go back to reference Rutgers EJ: Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005, 31 (6): 568-576. 10.1016/j.ejso.2005.02.008.CrossRefPubMed Rutgers EJ: Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005, 31 (6): 568-576. 10.1016/j.ejso.2005.02.008.CrossRefPubMed
21.
go back to reference Audretsch W, Rezai M, Kolotas C, Zamboglou N, Schnabel T, Bojar H: Tumor-specific immediate reconstruction (TSIR) in breast cancer patients. Perspect Plast Surg. 1998, 11: 71-106. Audretsch W, Rezai M, Kolotas C, Zamboglou N, Schnabel T, Bojar H: Tumor-specific immediate reconstruction (TSIR) in breast cancer patients. Perspect Plast Surg. 1998, 11: 71-106.
22.
go back to reference Losken A, Elwood ET, Styblo TM, Bostwick J: The role of reduction mammaplasty in reconstructing partial mastectomy defects. Plast Reconstr Surg. 2002, 109 (3): 968-975. 10.1097/00006534-200203000-00025. discussion 976-967.CrossRefPubMed Losken A, Elwood ET, Styblo TM, Bostwick J: The role of reduction mammaplasty in reconstructing partial mastectomy defects. Plast Reconstr Surg. 2002, 109 (3): 968-975. 10.1097/00006534-200203000-00025. discussion 976-967.CrossRefPubMed
23.
go back to reference Munhoz AM, Montag E, Arruda E, Pellarin L, Filassi JR, Piato JR, de Barros AC, Prado LC, Fonseca A, Baracat E, et al: Assessment of immediate conservative breast surgery reconstruction: a classification system of defects revisited and an algorithm for selecting the appropriate technique. Plast Reconstr Surg. 2008, 121 (3): 716-727. 10.1097/01.prs.0000299295.74100.fa.CrossRefPubMed Munhoz AM, Montag E, Arruda E, Pellarin L, Filassi JR, Piato JR, de Barros AC, Prado LC, Fonseca A, Baracat E, et al: Assessment of immediate conservative breast surgery reconstruction: a classification system of defects revisited and an algorithm for selecting the appropriate technique. Plast Reconstr Surg. 2008, 121 (3): 716-727. 10.1097/01.prs.0000299295.74100.fa.CrossRefPubMed
24.
go back to reference Baildam AD: Breast reconstruction – state of the art. Breast. 2006, 15 (Suppl 2): S27-30. 10.1016/S0960-9776(07)70014-0.CrossRefPubMed Baildam AD: Breast reconstruction – state of the art. Breast. 2006, 15 (Suppl 2): S27-30. 10.1016/S0960-9776(07)70014-0.CrossRefPubMed
Metadata
Title
Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients
Authors
Jürgen Hoffmann
Diethelm Wallwiener
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-108

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine